Assessment of frailty and comorbidities in cellular therapies patients in Italy: results of the GITMO Elderly-Survey (GITMO ELD-Survey).

IF 2.2 4区医学 Q3 HEMATOLOGY

Leukemia & Lymphoma Pub Date : 2025-01-15 DOI:10.1080/10428194.2025.2451723

Michele Malagola, Luca Castagna, Mirko Farina, Simone Pellizzeri, Eliana Degrandi, Elena Oldani, Simona Bassi, Giorgia Battipaglia, Carlo Borghero, Lucia Brunello, Alessandro Busca, Raffaella Ceretti, Patrizia Chiusolo, Michele Cimminiello, Vincenzo Federico, Camilla Frieri, Piero Galieni, Sara Galimberti, Andrea Gilioli, Annalisa Imovilli, Walter Barbieri, Chiara Nozzoli, Alessandra Picardi, Eugenia Piras, Nicola Polverelli, Lucia Prezioso, Stella Santarone, Renato Scalone, Ilaria Scortechini, Bianca Serio, Cristina Skert, Alessandro Spina, Elisabetta Terruzzi, Massimo Martino

引用次数: 0

查看原文本刊更多论文

评估意大利细胞治疗患者的衰弱和合并症：GITMO老年调查（GITMO老年调查）的结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Leukemia & Lymphoma 医学-血液学

CiteScore

4.10

自引率

3.80%

发文量

384

审稿时长

1.8 months

期刊介绍： Leukemia & Lymphoma in its fourth decade continues to provide an international forum for publication of high quality clinical, translational, and basic science research, and original observations relating to all aspects of hematological malignancies. The scope ranges from clinical and clinico-pathological investigations to fundamental research in disease biology, mechanisms of action of novel agents, development of combination chemotherapy, pharmacology and pharmacogenomics as well as ethics and epidemiology. Submissions of unique clinical observations or confirmatory studies are considered and published as Letters to the Editor